These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15735015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants.
    Miller DW, Vosseler S, Mirancea N, Hicklin DJ, Bohlen P, Völcker HE, Holz FG, Fusenig NE.
    Am J Pathol; 2005 Nov; 167(5):1389-403. PubMed ID: 16251423
    [Abstract] [Full Text] [Related]

  • 3. Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.
    Willhauck MJ, Mirancea N, Vosseler S, Pavesio A, Boukamp P, Mueller MM, Fusenig NE, Stark HJ.
    Carcinogenesis; 2007 Mar; 28(3):595-610. PubMed ID: 17056607
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J, Huang S, Armstrong EA, Fowler JF, Harari PM.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1477-85. PubMed ID: 16029810
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U, Fillbrandt R, Westphal M.
    Clin Cancer Res; 2005 Jul 01; 11(13):4934-40. PubMed ID: 16000592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.
    Zips D, Eicheler W, Geyer P, Hessel F, Dörfler A, Thames HD, Haberey M, Baumann M.
    Cancer Res; 2005 Jun 15; 65(12):5374-9. PubMed ID: 15958586
    [Abstract] [Full Text] [Related]

  • 12. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
    Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, Ellis LM.
    Clin Cancer Res; 2006 Apr 15; 12(8):2628-33. PubMed ID: 16638876
    [Abstract] [Full Text] [Related]

  • 13. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
    Holloway SE, Beck AW, Shivakumar L, Shih J, Fleming JB, Brekken RA.
    Ann Surg Oncol; 2006 Aug 15; 13(8):1145-55. PubMed ID: 16791450
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
    Ogawa Y, Suzuki T, Oikawa A, Hosono K, Kubo H, Amano H, Ito Y, Kitasato H, Hayashi I, Kato T, Sugimoto Y, Narumiya S, Watanabe M, Majima M.
    Biochem Biophys Res Commun; 2009 May 15; 382(4):720-5. PubMed ID: 19318087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.